NMRA vs WMB · $283.5M cap vs P/E 31, rev $11.95B
Neumora Therapeutics, Inc. (NMRA) versus Williams Companies Inc (WMB) — a side-by-side from cached financials, not a winner call.
Neumora Therapeutics, Inc. (NMRA) is a biotechnology company listed on NASDAQ.
Williams Companies Inc (WMB) is a oil & gas midstream company listed on NYSE.
NMRA does not have a complete income-statement cache yet.
Latest reported WMB revenue for 2025-12-31 was $11.95B. Net income was $2.62B. Revenue was up 13.8% from 2024-12-31 to 2025-12-31. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
NMRA currently screens at market cap $283.5M. WMB currently screens at market cap $87.14B and trailing P/E 31.3.
Not investment advice. Open the NMRA and WMB stock pages for the full models.
Not investment advice.